UNSPSC 51285409: Cefsumide

This classification denotes a cephalosporin antibiotic with the molecular formula C17H20N4O6S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 3642W81J7A, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(3-((methylsulfonyl)amino)phenyl)acetyl)amino)-3-methyl-8-oxo-, (6r-(6alpha,7beta(r*)))- but more generally known as cefsumide, which bears US NIH Compound Identifier 68718.

UNSPSC 51285409 Cefsumide, a Commodity code, shows little relevant recent state and local procurement activity. The two records in the available opportunity dataset do not align with cefsumide procurement — one documents an Illinois Department of Public Health piggyback pharmaceutical award for doxycycline and ciprofloxacin (antibiotics, not cefsumide), and the other captures a Seminole County, Florida solicitation for naloxone and drug deactivation systems, which fall outside the scope of the cefsumide code. The source provides no open RFPs, RFQs, IFBs, or ITBs for cefsumide or closely related third-generation cephalosporin antibiotics at the state or local level within the review window.

Without recent solicitations tagged to this code, the geographic spread and issuing-body patterns cannot be characterized. Buyers interested in cefsumide procurement may find activity under broader pharmaceutical family or class codes rather than this specific commodity designation, or procurement may occur through state pharmaceutical benefit managers, cooperative purchasing consortiums (such as MMCAP Infuse, visible in the doxycycline example above), or direct manufacturer relationships outside the traditional competitive bidding track. Monitor related codes in the 51280000–51289999 range and state-level pharmaceutical standing agreements for signals of future cefsumide demand.